ClinicalTrials.gg
Sign In
Drug

AR882 clinical trials

studies test it
9
open now
0
in phase 3
3
first study started
2019

How each study uses AR882 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

AR882 75 mg
3
AR882 50 mg
2
AR882 Dose 1
2
AR882 Dose 2
2

Studies by the year they started

9 studies that test it; most in 2021 (2)

Studies that test AR882, by start year
YearStudies
20191
20201
20212
20221
20242
20252

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
4
Phase 3
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Arthritis, Gouty
5
Hyperuricemia
1

Who runs them

Industry 9 · Other 0

Arthrosi Therapeutics (8) · Guangzhou Ruianbo Pharmaceutical Technology Co., Ltd (1)

Often tested with

Tested in the same studies.

Allopurinol (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test AR882.

Studies

Open first, then newest update. How each study uses AR882 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 9